Compounds > omega-n-methylarginine
Page last updated: 2024-09-03

omega-n-methylarginine and Left Ventricular Hypertrophy

omega-n-methylarginine has been researched along with Left Ventricular Hypertrophy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abel, ED; Hu, P; Litwin, SE; Sena, S; Sloan, CL; Symons, JD; Wang, X; Wende, AR; Yang, Y; Zhang, QJ1
Buchspies, D; Fink, L; Gassmann, M; Ghofrani, HA; Grimminger, F; Keller, S; Manz, D; Mehling, T; Quanz, K; Schermuly, RT; Seeger, W; Voswinckel, R; Weissmann, N1
MacCarthy, PA; Shah, AM1
Cave, AC; Gall, NP; Grieve, DJ; MacCarthy, PA; Shah, AM1
Hirooka, Y; Ichiki, T; Mohri, M; Takeshita, A1

Other Studies

5 other study(ies) available for omega-n-methylarginine and Left Ventricular Hypertrophy

ArticleYear
Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:1

    Topics: Acetylcholine; Analysis of Variance; Animals; Blotting, Western; Coronary Vessels; Echocardiography; Genotype; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Nitroprusside; omega-N-Methylarginine; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; Ventricular Dysfunction, Left

2011
Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
    Thrombosis and haemostasis, 2005, Volume: 94, Issue:3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Blood Pressure; Blood Vessels; Blood Viscosity; Cyclooxygenase Inhibitors; Erythropoietin; Hematocrit; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Up-Regulation; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents

2005
Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy.
    Circulation, 2000, Apr-18, Volume: 101, Issue:15

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Endothelium, Vascular; Guinea Pigs; Hypertrophy, Left Ventricular; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Substance P; Vasodilator Agents

2000
Divergent biological actions of coronary endothelial nitric oxide during progression of cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:2

    Topics: Animals; Disease Progression; Endothelium, Vascular; Enzyme Inhibitors; Guinea Pigs; Heart; Hypertrophy, Left Ventricular; Male; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organ Culture Techniques; Organ Size; Vasoconstriction; Vasodilation; Vasodilator Agents; Ventricular Pressure

2001
Endogenous nitric oxide prevents myocardial ischemia in patients with hypertension and left ventricular hypertrophy.
    American heart journal, 2002, Volume: 143, Issue:4

    Topics: Aged; Cardiac Catheterization; Coronary Circulation; Enzyme Inhibitors; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Nitric Oxide; omega-N-Methylarginine

2002